Autoantibody formation after alloimmunization inducing bystander immune hemolysis

Immunohematology

Volumn 25, Issue 1, 2009, Pages 9-12

  Mota, Mariza ^a   Bley, C ^a   Aravechia, M G ^a   Hamerschlak, N ^a   Sakashita, A ^a   Kutner, J M ^a   Castilho, L ^b  

^a HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Alloimmunization; Autoantibody; Bystander hemolysis; RBC transfusion

Indexed keywords

AUTOANTIBODY; BLOOD GROUP JK (B) ANTIBODY; HEMOGLOBIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; METHYLPREDNISOLONE; RHESUS C ANTIBODY; RITUXIMAB; UNCLASSIFIED DRUG;

AGED; ALLOIMMUNIZATION; ANEMIA; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY SCREENING; ARTHRALGIA; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUP KIDD SYSTEM; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; BYSTANDER IMMUNE HEMOLYSIS; CASE REPORT; COOMBS TEST; DISEASE SEVERITY; FEMALE; FEVER; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBINURIA; HEMOLYSIS; HUMAN; PRIORITY JOURNAL; SEROLOGY;

AGED; ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; BLOOD GROUP ANTIGENS; BLOOD GROUP INCOMPATIBILITY; BLOOD TRANSFUSION; ERYTHROCYTES; FEMALE; HEMOLYSIS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS;

EID: 66849101809     PISSN: 0894203X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Young PP, Uzieblo A, Trulock A, et al. Autoantibody formation following alloimmunization: are blood transfusions a risk factor for autoimmune hemolytic anemia? Transfusion 2004;44:67-72.
2. Ayun B, Padmanabhan S, Paley C, Chandrasekaran V. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion 2002;42:37-40.
3. Win N, Doughty H, Telfer P, Wild BJ, Pearson TC. Hyperhemolytic transfusion reaction in sickle cell disease. Transfusion 2001;41:323-328 (Pubitemid 32238528)
4. Vichinsky EP, Luban NL, Wright E, et al. Prospective RBC phenotype matching in a stroke prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 2001;41:1086-1092 (Pubitemid 32848083)
5. Cox J, Steane E, Cunningham G, Frenkle E. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease. Arch Intern Med 1988;148:2485-2489 (Pubitemid 18273084)
6. Dameshek W. Autoimmunity: theoretical aspects. Ann NY Acad Sci 1965;124:6-28.
7. Petz LD, Garratty G. Blood transfusion in autoimmune hemolytic anemia. In: Petz LD, Garratty G, eds. Acquired immune hemolytic anemias, 1st ed. New York: Churchill Livingstone, 1980:358-391
8. Garratty G. Novel mechanisms for immune destruction of circulating autologous cells. In: Silberstein LE, ed. Autoimmune disorders of blood. Bethesda, MD: American Association of Blood Banks, 1996:79-114.
9. Mollison PL, Engelfriet CP, Contreras M, eds. Blood transfusion in clinical medicine. Oxford: Blackwell Science, 1997:85.
10. Cook IA. Primary rhesus immunization of male volunteers. Br J Haematol 1971;20:369-375
11. Petz LD, Garratty G. Bystander immune hemolysis. In: Petz LD, Garratty G. Immune hemolytic anemias. 2nd ed. Philadelphia: Churchill Livingstone, 2004:358-364
12. Salama A, Bhakdi S, Mueller-Eckhardt C. Evidence suggesting the occurrence of C3- independent intravascular immune hemolysis. Reactive hemolysis in vivo. Transfusion 1987;27:49-53. (Pubitemid 17030035)
13. Reid ME, Rios M, Powell VI, Pierre C, Malavade V. DNA from blood samples can be used to genotype patients who have recently received a transfusion. Transfusion 2000;40:48-53. (Pubitemid 30053544)
14. Petz LD, Garraty G. Development of RBC autoantibodies and AIHA following transfusion. In: Petz LD, Garratty G. Immune hemolytic anemias. 2nd ed. Philadelphia: Churchill Livingstone, 2004:335-340
15. Petz LD. Bystander immune cytolysis. Transfus Med Rev 2006;20:110-140
16. Cox KO, Keast D. Erythrocyte autoantibodies induced in mice immunized with rat erythrocytes. Immunology 1973;25:531-539
17. Cox KO, Keast D. Autoimmune haemolytic anaemia induced in mice immunized with rat erythrocytes. Clin Exp Immunol 1974;17:319-327
18. Naysmith JD, Ortega-Oierres MG, Elson CJ. Rat erythrocyte-induced anti-erythrocyte autoantibody production and control in normal mice. Immunol Rev 1981;55:55-87. (Pubitemid 11157602)
19. Lalezari P, Talleyrand NP, Wenz B, et al. Development of direct antiglobulin reaction accompanying alloimmunization in a patient with RhD (D category III) phenotype. Vox Sang 1975;28:19-24.
20. Chaplin H Jr, Zarkowsky HS. Combined sickle cell disease and autoimmune hemolytic anemia. Arch Intern Med 1981;141:1091-1093
21. Argiolu F, Diana G, Arnone M, et al. High-dose intravenous immunoglobulin in the management of autoimmune hemolytic anemia complicating thalassemia major. Acta Haematol 1990;83:65-68 (Pubitemid 20043272)
22. Wodzinski MA, Collin RC, Booker DJ, Stamps R, Bellamy JD, Sokol RJ. Delayed hemolytic transfusion reaction and paroxysmal cold hemoglobinuria: an unusual association. Immunohematology 1997;13:54-57
23. Dameshek W, Levine P. Isoimmunization with Rh factor in acquired hemolytic anemia. N Engl J Med 1943;228:641-644